Literature DB >> 11565536

Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.

C Sabbà, M Gallitelli, G Palasciano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11565536     DOI: 10.1056/NEJM200109203451216

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Pharmacological therapy of vascular malformations of the gastrointestinal tract.

Authors:  Andrew Szilagyi; Maged P Ghali
Journal:  Can J Gastroenterol       Date:  2006-03       Impact factor: 3.522

Review 2.  Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review.

Authors:  Majid Almadi; Peter M Ghali; Andre Constantin; Jacques Galipeau; Andrew Szilagyi
Journal:  Can J Gastroenterol       Date:  2009-09       Impact factor: 3.522

Review 3.  Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

4.  Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide.

Authors:  Mohamed Aftab Alam; Sarmad Sami; Sathish Babu
Journal:  BMJ Case Rep       Date:  2011-11-08

Review 5.  Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century.

Authors:  M E Begbie; G M F Wallace; C L Shovlin
Journal:  Postgrad Med J       Date:  2003-01       Impact factor: 2.401

6.  Tranexamic acid for patients with nasal haemorrhage (epistaxis).

Authors:  Jonathan Joseph; Pablo Martinez-Devesa; Jenny Bellorini; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2018-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.